Cargando…
Safety and immunogenicity of an inactivated thimerosal‐free influenza vaccine in infants and children
Objective Few prospective studies of inactivated split virion influenza vaccine have been conducted in infants and children. Our objective was to evaluate the safety, reactogenicity and immunogenicity of a thimerosal‐free inactivated influenza vaccine (Fluvax(®); CSL Limited, Parkville, Australia)...
Autores principales: | Nolan, Terry, Richmond, Peter C., McVernon, Jodie, Skeljo, Maryanne V., Hartel, Gunter F., Bennet, Jillian, Basser, Russell L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941394/ https://www.ncbi.nlm.nih.gov/pubmed/19903213 http://dx.doi.org/10.1111/j.1750-2659.2009.00108.x |
Ejemplares similares
-
Absence of cross‐reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months–9 years: a prospective study
por: McVernon, Jodie, et al.
Publicado: (2010) -
Safety and tolerability of a 2009 trivalent inactivated split‐virion influenza vaccine in infants, children and adolescents
por: Lambert, Stephen B., et al.
Publicado: (2013) -
A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate Vaccine
por: Perrett, Kirsten P., et al.
Publicado: (2013) -
Inhibition of Influenza A Virus by Human Infant Saliva
por: Gilbertson, Brad, et al.
Publicado: (2019) -
Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model
por: Lee, Eun Young, et al.
Publicado: (2018)